A NIH grant was award to Dr. Hakami in 2017 for development of a novel and highly promising phage-based therapeutic strategy to treat bacterial infections. For a GMU press release and article on this award, please visit https://www2.gmu.edu/news/488311
MANASSAS, Va. — September 28, 2017 — Tasso, Inc. (Tasso), Ceres Nanosciences (Ceres), George Mason University (Mason), and the United States Army Medical Research Institute of Infectious Diseases (USAMRIID) today announced the commencement of a $11.7 million program, funded by the Defense Threat Reduction Agency (DTRA), to develop a reliable, safe, and simple universal surveillance platform for infectious disease outbreaks.
Read the press article: http://www.ceresnano.com/press
Sophisticated germ fighters found in alligator blood may help future soldiers in the field fend off infection, according to new research by George Mason University.
Read the press article: https://www2.gmu.edu/news/1455
Read the journal publication: http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0117394
George Mason researchers are seeking out naturally based remedies to beat back antibiotic-resistant bacteria—and finding success.
Read the press article: https://www2.gmu.edu/news/1457
The U.S. Medical Research Institute of lnfectious Diseases (USAMRIID) has announced intentions to award a new contract to Dr. Hakami of George Mason University for profiling of host responses to high priority pathogens.
Dr. Narayanan won the 2014 College of Science Dean’s Early-Career Excellence Award. This award is presented to a tenure-track faculty member in the College who has achieved notable success since January 2014 and has increased the profile of their Department and the College of Science.
We at The National Center for Biodefense and Infectious Diseases, George Mason University, eagerly look forward to welcoming you to our annual “Host Pathogen Interactions in Biodefense and Emerging Infectious Diseases” conference on the 12th of February, 2015.
We have had successful meetings in the past two years that have fostered many meaningful collaborations and have advertised novel research to the research community in the area. The focus of the meetings has been and will continue to be on interactions between pathogens and hosts following exposure to bacterial and viral agents and the applicability of the knowledge gained to design of novel diagnostics, therapeutics and vaccines.
We look forward to an enriching, interesting and beneficial meeting in 2015.
View all conference details on the NCBID calendar.
Drs. Monique van Hoek and Barney Bishop were awarded a collaborative grant with James Madison University to study antimicrobial activity in the bedbug, Cimex lectularius.